KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Net Cash Flow (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Net Cash Flow data on record, last reported at -$701.6 million in Q4 2025.

  • For Q4 2025, Net Cash Flow fell 2651.37% year-over-year to -$701.6 million; the TTM value through Dec 2025 reached $47.4 million, down 62.62%, while the annual FY2025 figure was $47.4 million, 62.62% down from the prior year.
  • Net Cash Flow reached -$701.6 million in Q4 2025 per ZBH's latest filing, down from $739.2 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $852.2 million in Q1 2025 and bottomed at -$842.4 million in Q2 2025.
  • Average Net Cash Flow over 5 years is -$3.7 million, with a median of -$20.6 million recorded in 2023.
  • The widest YoY moves for Net Cash Flow: up 5083.63% in 2025, down 2861.97% in 2025.
  • A 5-year view of Net Cash Flow shows it stood at -$442.2 million in 2021, then soared by 58.91% to -$181.7 million in 2022, then soared by 163.95% to $116.2 million in 2023, then plummeted by 121.94% to -$25.5 million in 2024, then plummeted by 2651.37% to -$701.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Cash Flow were -$701.6 million in Q4 2025, $739.2 million in Q3 2025, and -$842.4 million in Q2 2025.